It is primarily Ozempic is available as an injection for under-the-skin, or subcutaneous use
Clinical studies show that participants experienced a mean weight loss of 15% over 68 weeks: In 4 weeks, participants experienced an average of 2% weight loss In 8 weeks, they experienced 4% weight loss The good news is that most of the people in the study lost weight on Wegovy: Over 86% of participants lost at least 5% of their body weight About 70% lost 10% of their body weight or more Note: The FDA has not approved Ozempic and Rybelsus for weight loss
Those switched to placebo regained approximately half their lost weight within 52 weeks
Thousands of people face this transition every month, and the advice they receive ranges from confusing to contradictory
Instead, people often describe: Feeling full sooner during meals Hunger returning more slowly Less intense cravings Easier decision-making around food This is because semaglutide slows digestion and influences hunger signaling in the brain, helping appetite feel more manageable rather than overwhelming
Understanding the full spectrum of Semaglutides effects is crucial for maximizing its benefits while minimizing discomforts, such as the unexpected hiccup